GSK3B and Alzheimer disease: Conversely, decreased levels of GSK3B were observed in the AD patients compared to NCs when the least stable RGs were used for data normalization in the CB (Fig. 4H), whereas no differences were identified in the CB for the most stable RGs (Fig. 4J).